- Home
- CRON vs ATTO Comparison
CRON vs ATTO Comparison
Compare CRON & ATTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | ATTO |
|---|---|---|
| Founded | N/A | 2023 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.0B |
| IPO Year | 2015 | 2026 |
Fundamental Metrics
Financial Performance| Metric | CRON | ATTO |
|---|---|---|
| Price | $3.23 | $16.51 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $42.20 |
| AVG Volume (30 Days) | ★ 757.9K | 367.7K |
| Earning Date | 11-05-2026 | 09-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.12 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $46.73 | N/A |
| Revenue Next Year | $23.43 | N/A |
| P/E Ratio | $26.83 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $2.28 | $15.48 |
| 52 Week High | $3.61 | $28.00 |
Technical Indicators
Market Signals| Indicator | CRON | ATTO |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 36.53 |
| Support Level | $2.65 | $16.39 |
| Resistance Level | $3.28 | $18.38 |
| Average True Range (ATR) | 0.09 | 1.33 |
| MACD | -0.02 | -0.26 |
| Stochastic Oscillator | 23.03 | 16.64 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About ATTO Attovia Therapeutics Inc. Common Stock
Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.